Press Releases & Media Statements
July 18, 2024
First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones
July 18, 2024
New affordability initiative with GoodRx for our biosimilar
July 17, 2024
New effort to help improve C-R-M health outcomes
June 07, 2024